Yuen KS, Ye ZW, Fung SY, Chan CP, Jin DY. SARS-CoV-2 and COVID-19: The most important research questions. Cell Biosci. 2020;10:40.
Article PubMed PubMed Central Google Scholar
Fodor A, Tiperciuc B, Login C, Orasan OH, Lazar AL, Buchman C, et al. Endothelial dysfunction, inflammation, and oxidative stress in COVID-19-mechanisms and therapeutic targets. Oxid Med Cell Longev. 2021;2021:8671713.
Article PubMed PubMed Central Google Scholar
Schnaubelt S, Oppenauer J, Tihanyi D, Mueller M, Maldonado-Gonzalez E, Zejnilovic S, et al. Arterial stiffness in acute COVID-19 and potential associations with clinical outcome. J Intern Med. 2021;290:437–43.
Article CAS PubMed PubMed Central Google Scholar
Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020;41:3038–44.
Article CAS PubMed Google Scholar
Mezoh G, Crowther NJ. Endothelial dysfunction as a primary consequence of SARS-CoV-2 Infection. Adv Exp Med Biol. 2021;1321:33–43.
Article CAS PubMed Google Scholar
Ambrosino P, Calcaterra IL, Mosella M, Formisano R, D’Anna SE, Bachetti T, et al. Endothelial dysfunction in COVID-19: a unifying mechanism and a potential therapeutic target. Biomedicines. 2022;10:812.
Article CAS PubMed PubMed Central Google Scholar
de Rooij L, Becker LM, Carmeliet P. A role for the vascular endothelium in post-acute COVID-19? Circulation. 2022;145:1503–5.
Gladka MM, Maack C. The endothelium as Achilles’ heel in COVID-19 patients. Cardiovasc Res. 2020;116:e195–e7.
Article CAS PubMed Google Scholar
Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142:1609–11.
Article CAS PubMed PubMed Central Google Scholar
Ma Z, Yang KY, Huang Y, Lui KO. Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications. J Mol Cell Cardiol. 2021;164:69–82.
Article PubMed PubMed Central Google Scholar
Flaumenhaft R, Enjyoji K, Schmaier AA. Vasculopathy in COVID-19. Blood. 2022;140:222–35.
Article CAS PubMed Google Scholar
Basta G. Direct or indirect endothelial damage? An unresolved question. EBioMedicine. 2021;64:103215.
Article CAS PubMed PubMed Central Google Scholar
Kandhaya-Pillai R, Yang X, Tchkonia T, Martin GM, Kirkland JL, Oshima J. TNF-α/IFN-γ synergy amplifies senescence-associated inflammation and SARS-CoV-2 receptor expression via hyper-activated JAK/STAT1. Aging Cell. 2022;21:e13646.
Article CAS PubMed PubMed Central Google Scholar
Nägele MP, Haubner B, Tanner FC, Ruschitzka F, Flammer AJ. Endothelial dysfunction in COVID-19: Current findings and therapeutic implications. Atherosclerosis. 2020;314:58–62.
Article PubMed PubMed Central Google Scholar
Xu S, Ilyas I, Little PJ, Li H, Kamato D, Zheng X, et al. Endothelial dysfunction in atherosclerotic cardiovascular diseases and beyond: from mechanism to pharmacotherapies. Pharmacol Rev. 2021;73:924–67.
Article CAS PubMed Google Scholar
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26:1017–32.
Article CAS PubMed Google Scholar
Villar J, Kacmarek RM. The American-European Consensus Conference definition of the acute respiratory distress syndrome is dead, long live positive end-expiratory pressure! Med Intensiv. 2012;36:571–5.
Hussain M, Khurram Syed S, Fatima M, Shaukat S, Saadullah M, Alqahtani AM, et al. Acute respiratory distress syndrome and COVID-19: a literature review. J Inflamm Res. 2021;14:7225–42.
Article CAS PubMed PubMed Central Google Scholar
Filbin MR. Insights into endotheliopathy in COVID-19. Am J Respir Crit Care Med. 2022. https://doi.org/10.1164/rccm.202207-1258ED.
Six I, Guillaume N, Jacob V, Mentaverri R, Kamel S, Boullier A, et al. The endothelium and COVID-19: an increasingly clear link brief title: endotheliopathy in COVID-19. Int J Mol Sci. 2022;23:6196.
Article CAS PubMed PubMed Central Google Scholar
Amraei R, Yin W, Napoleon MA, Suder EL, Berrigan J, Zhao Q, et al. CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2. ACS Cent Sci. 2021;7:1156–65.
Article CAS PubMed PubMed Central Google Scholar
Colunga Biancatelli RML, Solopov PA, Sharlow ER, Lazo JS, Marik PE, Catravas JD. The SARS-CoV-2 spike protein subunit S1 induces COVID-19-like acute lung injury in Κ18-hACE2 transgenic mice and barrier dysfunction in human endothelial cells. Am J Physiol Lung Cell Mol Physiol. 2021;321:L477–l84.
Article PubMed PubMed Central Google Scholar
Joffre J, Rodriguez L, Matthay ZA, Lloyd E, Fields AT, Bainton RJ, et al. COVID-19-Associated lung microvascular endotheliopathy: a “from the bench” perspective. Am J Respir Crit Care Med. 2022. https://doi.org/10.1164/rccm.202107-1774OC.
Ashour L. Roles of the ACE/Ang II/AT1R pathway, cytokine release, and alteration of tight junctions in COVID-19 pathogenesis. Tissue Barriers. 2022; 2090792. https://doi.org/10.1080/21688370.2022.2090792.
Vassiliou AG, Kotanidou A, Dimopoulou I, Orfanos SE. Endothelial damage in acute respiratory distress syndrome. Int J Mol Sci. 2020;21:8793.
Article CAS PubMed Central Google Scholar
Liu Y, Zhang HG. Vigilance on new-onset atherosclerosis following SARS-CoV-2 infection. Front Med. 2020;7:629413.
Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116:1666–87.
Article CAS PubMed PubMed Central Google Scholar
Chen L, Li X, Chen M, Feng Y, Xiong C. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res. 2020;116:1097–100.
Article CAS PubMed Google Scholar
Katsoularis I, Fonseca-Rodríguez O, Farrington P, Lindmark K, Fors Connolly AM. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet (Lond, Engl). 2021;398:599–607.
Fardman A, Zahger D, Orvin K, Oren D, Kofman N, Mohsen J, et al. Acute myocardial infarction in the Covid-19 era: Incidence, clinical characteristics and in-hospital outcomes-A multicenter registry. PLoS One. 2021;16:e0253524.
Article CAS PubMed PubMed Central Google Scholar
Toscano O, Cosentino N, Campodonico J, Bartorelli AL, Marenzi G. Acute myocardial infarction during the COVID-19 pandemic: an update on clinical characteristics and outcomes. Front Cardiovasc Med. 2021;8:648290.
Article CAS PubMed PubMed Central Google Scholar
Aye YN, Mai AS, Zhang A, Lim OZH, Lin N, Ng CH, et al. Acute myocardial infarction and myocarditis following COVID-19 vaccination. QJM. 2021. https://doi.org/10.1093/qjmed/hcab252.
Kondo Y, Larabee JL, Gao L, Shi H, Shao B, Hoover CM, et al. L-SIGN is a receptor on liver sinusoidal endothelial cells for SARS-CoV-2 virus. JCI insight. 2021;6:e148999.
Article PubMed Central Google Scholar
Saviano A, Baumert TF. Unraveling the role of liver sinusoidal endothelial cells in COVID-19 liver injury. J Hepatol. 2021;75:503–5.
Article CAS PubMed PubMed Central Google Scholar
McConnell MJ, Kawaguchi N, Kondo R, Sonzogni A, Licini L, Valle C, et al. Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy. J Hepatol. 2021;75:647–58.
Article CAS PubMed PubMed Central Google Scholar
Jothimani D, Venugopal R, Abedin MF, Kaliamoorthy I, Rela M. COVID-19 and the liver. J Hepatol. 2020;73:1231–40.
Article CAS PubMed PubMed Central Google Scholar
Alexander MP, Mangalaparthi KK, Madugundu AK, Moyer AM, Adam BA, Mengel M, et al. Acute kidney injury in severe COVID-19 has similarities to sepsis-associated kidney injury: a multi-omics study. Mayo Clin Proc. 2021;96:2561–75.
Article CAS PubMed Google Scholar
Henry BM, de Oliveira MHS, Cheruiyot I, Benoit JL, Cooper DS, Lippi G, et al. Circulating level of Angiopoietin-2 is associated with acute kidney injury in coronavirus disease 2019 (COVID-19). Angiogenesis. 2021;24:403–6.
Article CAS PubMed PubMed Central Google Scholar
Poloni TE, Medici V, Moretti M, Visonà SD, Cirrincione A, Carlos AF, et al. COVID-19-related neuropathology and microglial activation in elderly with and without dementia. Brain Pathol (Zur, Switz). 2021;31:e12997.
留言 (0)